Product name:Vandetanib
CAS:443913-73-3
Molecular Formula:C22H24BrFN4O2
Formula Weight:475.35g/mol
Description:
It is a medication currently undergoing clinical trials as a potential targeted treatment for non–small-cell lung cancer.Vandetanib is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR). It is a tyrosine kinase inhibitor.